Elizabeth Gourd. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » AcrylamidesAniline CompoundsAntineoplastic Agents, Immunological/administration & dosageAntineoplastic Agents, Immunological/adverse effectsBiomarkers, Tumor/antagonists & inhibitorsBiomarkers, Tumor/geneticsBrain Neoplasms/drug therapyBrain Neoplasms/geneticsBrain Neoplasms/secondaryCarcinoma, Non-Small-Cell Lung/drug therapyCarcinoma, Non-Small-Cell Lung/geneticsCarcinoma, Non-Small-Cell Lung/secondaryClinical Trials, Phase III as TopicErbB Receptors/antagonists & inhibitorsErbB Receptors/geneticsGenetic Predisposition to DiseaseHumansLung Neoplasms/drug therapyLung Neoplasms/geneticsLung Neoplasms/pathologyMutationPhenotypePiperazines/administration & dosagePiperazines/adverse effectsProgression-Free SurvivalProtein Kinase Inhibitors/administration & dosageProtein Kinase Inhibitors/adverse effectsRandomized Controlled Trials as TopicTime Factors
Substances： See more » AcrylamidesAniline CompoundsAntineoplastic Agents, ImmunologicalBiomarkers, TumorPiperazinesProtein Kinase InhibitorsosimertinibEGFR protein, humanErbB Receptors
Year: 2018 PMID： 30197172 DOI： 10.1016/S1470-2045(18)30677-6
Source DB: PubMed Journal: Lancet Oncol ISSN： 1470-2045 Impact factor: 41.316